SAPMY vs. UTHR
SAPMY (Saipem SpA ADR) and UTHR (United Therapeutics Corporation) are both stocks. SAPMY operates in Oil & Gas Equipment & Services (Energy), while UTHR operates in Biotechnology (Healthcare). Over the past 5 years, SAPMY returned 3.63%/yr vs 23.86%/yr for UTHR. At a 0.08 correlation, their price movements are largely independent.
Performance
SAPMY vs. UTHR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SAPMY achieves a 102.80% return, which is significantly higher than UTHR's 12.28% return.
SAPMY
- 1D
- 3.37%
- 1M
- 0.36%
- 6M
- 99.42%
- YTD
- 102.80%
- 1Y
- 102.31%
- 3Y*
- 148.08%
- 5Y*
- 3.63%
- 10Y*
- —
UTHR
- 1D
- -0.98%
- 1M
- 0.20%
- 6M
- 13.21%
- YTD
- 12.28%
- 1Y
- 85.12%
- 3Y*
- 35.14%
- 5Y*
- 23.86%
- 10Y*
- 17.09%
SAPMY vs. UTHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SAPMY Saipem SpA ADR | 102.80% | 382.30% | 50.00% | 45.45% | -93.87% | -22.79% | -44.06% | 30.33% | -17.61% | 18.54% |
UTHR United Therapeutics Corporation | 12.28% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 13.18% |
Correlation
The correlation between SAPMY and UTHR is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.03 |
Correlation (All Time) Calculated using the full available price history since Aug 24, 2017 | 0.08 |
Fundamentals
SAPMY:
$10.09B
UTHR:
$23.22B
SAPMY:
€0.24
UTHR:
$27.12
SAPMY:
3.75
UTHR:
20.17
SAPMY:
0.08
UTHR:
8.19
SAPMY:
0.66
UTHR:
4.38
SAPMY:
€15.52B
UTHR:
$3.17B
SAPMY:
€5.53B
UTHR:
$2.74B
SAPMY:
€1.58B
UTHR:
$1.75B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SAPMY vs. UTHR — Risk / Return Rank
SAPMY
UTHR
SAPMY vs. UTHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Saipem SpA ADR (SAPMY) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SAPMY | UTHR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.54 | ||
| Sortino ratioReturn per unit of downside risk | -1.95 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.45 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 3.51 | 7.77 | -4.26 |
| Martin ratioReturn relative to average drawdown | 8.31 | 16.43 | -8.12 |
Loading charts...
Drawdowns
SAPMY vs. UTHR - Drawdown Comparison
The maximum SAPMY drawdown since its inception was -99.36%, which is greater than UTHR's maximum drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for SAPMY and UTHR.
Loading charts...
Drawdown Indicators
| SAPMY | UTHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.36% | -93.18% | -6.18% |
Max Drawdown (1Y)Largest decline over 1 year | -29.28% | -10.64% | -18.64% |
Max Drawdown (3Y)Largest decline over 3 years | -37.14% | -33.00% | -4.14% |
Max Drawdown (5Y)Largest decline over 5 years | -99.36% | -33.00% | -66.36% |
Max Drawdown (10Y)Largest decline over 10 years | — | -55.56% | — |
Current DrawdownCurrent decline from peak | -57.12% | -8.33% | -48.79% |
Average DrawdownAverage peak-to-trough decline | -62.64% | -35.24% | -27.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.35% | 5.03% | +7.32% |
Volatility
SAPMY vs. UTHR - Volatility Comparison
Saipem SpA ADR (SAPMY) has a higher volatility of 20.60% compared to United Therapeutics Corporation (UTHR) at 5.97%. This indicates that SAPMY's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SAPMY | UTHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.60% | 5.97% | +14.63% |
Volatility (6M)Calculated over the trailing 6-month period | 48.22% | 25.88% | +22.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 85.79% | 47.51% | +38.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 275.56% | 35.03% | +240.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 209.31% | 34.96% | +174.35% |
Dividends
SAPMY vs. UTHR - Dividend Comparison
SAPMY's dividend yield for the trailing twelve months is around 3.88%, while UTHR has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
SAPMY Saipem SpA ADR | 3.88% | 77.01% | 0.00% | 0.00% | 169.09% | 0.00% | 0.22% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SAPMY vs. UTHR - Financials Comparison
This section allows you to compare key financial metrics between Saipem SpA ADR and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SAPMY vs. UTHR - Profitability Comparison
SAPMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Saipem SpA ADR reported a gross profit of 998.00M and revenue of 3.53B. Therefore, the gross margin over that period was 28.3%.
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.
SAPMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Saipem SpA ADR reported an operating income of 157.00M and revenue of 3.53B, resulting in an operating margin of 4.5%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.
SAPMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Saipem SpA ADR reported a net income of 78.00M and revenue of 3.53B, resulting in a net margin of 2.2%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.
Frequently Asked Questions
SAPMY and UTHR have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SAPMY has higher volatility (20.60%) compared to UTHR (5.97%). In terms of maximum drawdown, SAPMY dropped -99.36% vs UTHR's -93.18%.
UTHR currently has the higher Sharpe Ratio (1.74 vs 1.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SAPMY and UTHR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer